Health
Lilly’s Obesity Drug Sales Rise 60% in India Amid Rising Demand
A Mounjaro injection pen.
Photographer: Sandy Huffaker/The Washington Post/Getty Images
Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full month of being on offer in the South Asian country, which has the world’s third-highest number of obese people.
The US drugmaker sold 126 million rupees ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies. Sales of its 5 mg version more than doubled to about 75 million rupees, while revenue from the 2.5 mg shot was 51 million rupees.